Muscle Repair in Aging: A New Molecule Shows Promise

Last updated: November 4, 2026

Carrying groceries up the stairs can take more effort than it did a year ago. That gradual change may reflect more than declining strength. It can also point to a repair system that becomes less reliable with age.

Research from Japan suggests a compound called lipoic acid trisulfide (LASSS) could strengthen one of the key signals involved in muscle regeneration. The laboratory result is promising, but it is not yet a treatment for aging muscle loss.

What the research found

Scientists at Kyushu University's Faculty of Agriculture, led by Professor Ryuichi Tatsumi, investigated LASSS and another antioxidant compound, glutathione trisulfide (GSSSG). Their findings were published in Scientific Reports.

Both compounds reduced nitration at two important sites on hepatocyte growth factor, or HGF: Y198 and Y250. Nitration is a chemical modification that can alter a protein's structure and interfere with its activity. At these sites, nitration reduces HGF's ability to attach to its c-met receptor.

HGF normally helps activate satellite cells, stem cells positioned alongside muscle fibers. After injury or mechanical stimulation, HGF is released and binds to c-met on these dormant cells. That interaction helps awaken them so they can multiply, mature and participate in repairing muscle tissue.

Reducing nitration alone did not fully restore HGF's receptor-binding ability. The researchers therefore increased the amount of trisulfide relative to HGF, changing the molar ratio from 1:4000 to 1:8000.

At the higher ratio, LASSS produced an additional effect: compared with untreated HGF, HGF exposed to LASSS had more than twice the binding affinity for c-met. It also became more resistant to nitration-related loss of function, particularly at Y198.

The effect was specific to LASSS. GSSSG also reduced nitration in the earlier experiments, but it did not produce the same improvement in receptor binding.

Why aging disrupts muscle repair

Skeletal muscle can repair itself after wear and injury, but that capacity becomes less reliable with age. Muscle tissue may develop scar tissue, accumulate fat and lose specialized fibers associated with rapid, powerful movement. These changes can make ordinary activities more difficult and reduce mobility and physical independence.

The researchers' earlier work suggests that HGF may not simply disappear as people age. Instead, it can be chemically altered after it is produced. Nitration at Y198 and Y250 can weaken the protein's connection with c-met, potentially limiting the activation of the satellite cells needed for regeneration.

That distinction matters. A signal that is present but chemically impaired is not the same as a signal that is absent, and the finding points toward a different kind of intervention than simply increasing the amount of HGF.

Our analysis: why it matters

The central insight is that antioxidant activity did not tell the whole story. Both compounds reduced the chemical modification they were tested against, yet only LASSS substantially improved HGF's ability to bind to its receptor.

That suggests researchers cannot evaluate these compounds by one property alone. Their effects may depend on how the molecule interacts with HGF, the concentration relative to the protein and the particular sites affected. It also gives follow-up studies a more precise target: protecting or restoring HGF-c-met signaling, rather than pursuing a general reduction in oxidative stress.

The trade-off is equally important. Stronger binding is a mechanistic result, not proof of stronger muscle repair. The work was conducted in laboratory experiments, so it does not establish that LASSS can safely improve regeneration in living organisms or older adults.

The study also does not show that any decline in muscle function can be reversed. It identifies a way to enhance one step in a repair pathway. Whether that produces meaningful improvements in tissue repair, strength or mobility remains a separate question.

Who should care

Researchers should watch whether the result can be reproduced in aging muscle and whether improved HGF-c-met binding leads to better tissue regeneration. Safety, delivery and appropriate dosing will also need testing in living models before human trials.

People following regenerative medicine should note that LASSS represents a specific molecular approach rather than a general-purpose antioxidant. Its apparent advantage over GSSSG cannot be assumed to apply to other compounds in the trisulfide family.

Older adults concerned about strength or mobility should treat the findings as a reason to discuss the problem with a healthcare professional, not as evidence for taking LASSS. No clinical evidence supports that use, and no human safety or dosing profile has been established for muscle repair.

What to watch next

The next decisive questions extend beyond whether LASSS works in people at all. Researchers will need to determine whether it improves actual muscle regeneration, whether the benefit appears in aging muscle, and whether the effect persists outside laboratory conditions.

If animal and human studies confirm the mechanism, trials would need to measure functional outcomes rather than molecular binding alone. A compound could strengthen HGF-c-met signaling without delivering a meaningful improvement in strength, mobility or physical independence.

For now, the finding is best understood as a promising proof of mechanism. LASSS did more than protect HGF from nitration; in the tested conditions, it made the protein bind more strongly to a receptor that helps activate the body's muscle stem cells. That is an important experimental step, but clinical benefit remains unproven.

Key takeaways

• LASSS more than doubled HGF's binding affinity for the c-met receptor under the tested laboratory conditions.
• The effect went beyond reducing nitration; GSSSG reduced nitration without producing the same receptor-binding improvement.
• The work supports a specific mechanism involving HGF, satellite cells and muscle regeneration, but it does not demonstrate that muscle loss can be reversed.
• Human safety, dosing and real-world muscle benefits remain unknown, so the findings do not support self-treatment with LASSS.